SCHEMBL5504832

SCHEMBL5504832

Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-n1cnc2ccccc2c1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.57
EPHB4 P54760 2/20 0.55
BRAF P15056 6/20 0.55
ABL1 P00519 2/20 0.53
BCR P11274 1/20 0.53
TEK Q02763 3/20 0.53
KIT P10721 2/20 0.52
LCK P06239 2/20 0.52
KDR P35968 2/20 0.52
CSF1R P07333 1/20 0.52
BTK Q06187 1/20 0.52
FES P07332 1/20 0.51
RET P07949 1/20 0.51
PDGFRB P09619 1/20 0.51
FGFR1 P11362 1/20 0.51
SRC P12931 1/20 0.51
PDGFRA P16234 1/20 0.51
FLT1 P17948 1/20 0.51
FGFR3 P22607 1/20 0.51
EPHA3 P29320 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4881020 0.90 MAPK14 (0.59) MAPK14EPHB4BRAFABL1BCR
SCHEMBL4878817 0.90 MAPK14 (0.53) MAPK14EPHB4BRAFABL1BCR
SCHEMBL4877990 0.90 MAPK14 (0.58) MAPK14EPHB4BRAFABL1BCR
SCHEMBL4884285 0.88 MAPK14 (0.66) MAPK14BRAFABL1BCRTEK
SCHEMBL4831532 0.88 MAPK14 (0.70) MAPK14
SCHEMBL4884817 0.86 TEK (0.53) MAPK14EPHB4BRAFABL1BCR
SCHEMBL27682252 0.85 AURKA (0.56) MAPK14EPHB4BRAFABL1BCR
SCHEMBL4890582 0.84 MAPK14 (0.78) MAPK14BRAF
SCHEMBL4882125 0.84 MAPK14 (0.69) MAPK14BRAF
SCHEMBL4884245 0.83 MAPK14 (0.53) MAPK14BRAFABL1BCRTEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1789400-A1 QUINAZOLINONE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS AstraZeneca AB (SE) 2007-05-30 EP claimed
WO-2006024836-A1 QUINAZOLINONE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS ASTRAZENECA AB (SE) 2006-03-09 WO claimed